Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05141721
Title A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gritstone bio, Inc.

colorectal cancer


Atezolizumab + GRT-C901 + GRT-R902 + Ipilimumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST